Our Founder and CEO

Our founder and CEO

  • Dr. Pi-Hui Liang joined ImmunAdd Inc. as the CEO in 2023, bringing over 30 years of experience in drug discovery and pharmaceuticals to enhance product development and progress at ImmunAdd.
  • Prior to join ImmunAdd, Dr. Liang was a professor at the School of Pharmacy, National Taiwan University, focusing on drug chemistry, immunopharmaceuticals, and anticancer drug development. She has authored over 60 academic papers and most of as the corresponding authors, holds more than 40 patents, and has been honored with numerous national awards such as the Outstanding Research Award from the National Science Council, Future Tech Award, National Innovation Award, Wu Huo-Shi Medical Award, and etc.
  • Dr. Liang obtained her Ph.D. from the School of Pharmacy at National Taiwan University, completed postdoctoral research at the Academia Sinica and the Scripps Research Institute in the United States, mentored by the pioneering expert in glycoscience, Academician Dr. Chi-Huey Wong.

2015 began to study and synthesis saponin adjuvants

2021 Our adjuvant won National Innovation Award of Taiwan

2022 Contract from Ministry of Economic Affair

2022 ImmunAdd founded

2022 Our adjuvant works won Future Tech Award

2023 Pre-A fund raising

2023 ImmunAdd founder, Pi-Hui Liang, PhD received the 2023 Taiwan National Science and Technology Council (NSTC) Outstanding Research Award in the field of Pharmacy